316. Carnitine cycle disorder Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 4 / Drugs : 10 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 11

Drugs and their primary sponsors and trial info

Bezafibrate
   Rigshospitalet, Denmark
      2009   Phase 2   NCT00983788   Denmark;
Bezafibrate (drug)
   Assistance Publique - Hôpitaux de Paris
      2006   Phase 3   NCT00336167   France;
Break in L-carnitine treatment
   Karen Lindhardt Madsen
      2013   -   NCT02226419   -
Glycerol/Saline
   Oregon Health and Science University
      2016   -   NCT02517307   United States;
Hyperinsulinemic euglycemic clamp
   Oregon Health and Science University
      2016   -   NCT02517307   United States;
Intralipid/Heparin
   Oregon Health and Science University
      2016   -   NCT02517307   United States;